Ecsemevista (exemestane) coated tablets 25 mg. №30

$160.00

Manufacturer: Ukraine

Category:

Description

Adjuvant therapy in women with invasive early-stage breast cancer with a positive test for estrogen receptors in the postmenopausal period after 2-3 yEars and Nose of initial adjuvant therapy with tamoxifen. Treatment of advanced breast cancer in women with natural or induced postmenopausal status, in which the progression of the disease was detected after antiestrogen therapy. Ni has been shown to be effective in patients with a negative test for estrogen receptors.Adjuvant therapy in women with invasive early-stage breast cancer with a positive test for estrogen receptors in the postmenopausal period after 2-3 yEars and Nose of initial adjuvant therapy with tamoxifen. Treatment of advanced breast cancer in women with natural or induced postmenopausal status, in which the progression of the disease was detected after antiestrogen therapy. Ni has been shown to be effective in patients with a negative test for estrogen receptors.